SCHMIDT ERIC THOMAS has filed 5 insider transactions across 2 companies since March 2023.
Most recent transaction: a grant/award of 5200 shares of Revolution Medicines, Inc. ($RVMD) on June 08, 2023.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 8, 2023 | Revolution Medicines, Inc. | $RVMD | SCHMIDT ERIC THOMAS | Not found | A | Common Stock | 5200 | $0.00 | 21,251.0000 | 0 | 32.40% | 0.00% |
| June 8, 2023 | Revolution Medicines, Inc. | $RVMD | SCHMIDT ERIC THOMAS | Not found | A | Stock Option (Right to Buy) | 18400 | $0.00 | 18,400.0000 | 0 | 9999.99% | 0.00% |
| March 22, 2023 | Allogene Therapeutics, Inc. | $ALLO | SCHMIDT ERIC THOMAS | Chief Financial Officer | A | Common Stock | 558094 | $0.00 | 2,015,034.0000 | 0 | 38.31% | 0.00% |
| March 22, 2023 | Allogene Therapeutics, Inc. | $ALLO | SCHMIDT ERIC THOMAS | Chief Financial Officer | A | Stock Option (Right to Buy) | 432738 | $0.00 | 432,738.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2023 | Allogene Therapeutics, Inc. | $ALLO | SCHMIDT ERIC THOMAS | Chief Financial Officer | F | Common Stock | 35879 | $5.47 | 1,456,940.0000 | 0 | 2.40% | 0.00% |